Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chaft, J.
246  Ergebnisse:
Personensuche X
?
1

145MO Updated survival, efficacy and safety of adjuvant (ad..:

Carbone, D.P. ; Waqar, S.N. ; Chaft, J....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S90-S91 , 2023
Link: https://doi.org/10.1016/..
 
?
2

A Novel FDG PET and Mean Lung Dose Model to Identify Stage ..:

Thor, M. ; Shepherd, A.F. ; Apte, A....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S169 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Patterns of Failure in Resectable Stage I-IIIA NSCLC Treate..:

Mao, S. ; Rosner, S. ; Forde, P....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e381-e382 , 2022
Link: https://doi.org/10.1016/..
 
?
4

OA14.06 T-Cell Dynamics in Response to Neoadjuvant Atezoliz..:

Oezkan, F. ; Hilz, S. ; Grindheim, J....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S38-S39 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Biomarkers Associated with Pulmonary Exacerbations in a Pro..:

Moore, Z.R. ; Huang, X. ; Lobaugh, S....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e528 , 2022
Link: https://doi.org/10.1016/..
 
?
6

NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort..:

Tian, S. ; Kozono, D.E. ; Ohri, N....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e392-e393 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Tumor Mutational Burden Predicts Progression-Free Survival ..:

Shaverdian, N. ; Shepherd, A.F. ; Offin, M....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e390-e391 , 2022
Link: https://doi.org/10.1016/..
 
?
8

EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies i..:

Lee, J.M. ; Sepesi, B. ; Toloza, E.M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S233-S234 , 2022
Link: https://doi.org/10.1016/..
 
?
9

A Pre-Treatment PET And CT-Derived Model for Progression-Fr..:

Thor, M. ; Fitzgerald, K.J. ; Apte, A....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e87 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Final Results of a Phase I Trial of Stereotactic Body Radio..:

Zhang, S.Y. ; Chaft, J. ; Wu, A.J....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e99 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Durvalumab with Concurrent Definitive Radiation Therapy (DA..:

Rimner, A. ; Offin, M. ; Shaverdian, N....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e929 , 2020
Link: https://doi.org/10.1016/..
 
?
12

One-Year Disease Outcomes in Stage III Non-Small Cell Lung ..:

Shaverdian, N. ; Shepherd, A.F. ; Offin, M....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e113 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Predicting Tumor Progression in Early Stage Non-small Cell ..:

Thor, M. ; Fitzgerald, K.J. ; Iyer, A....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E491 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Real-World Evaluation of Consolidative Durvalumab in Locall..:

Shaverdian, N. ; Zhang, Z. ; Lobaugh, S....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E531 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Genetic Predictors of Response to Chemoradiation in Stage I..:

Luo, L. ; Samstein, R. ; Dick-Godfrey, R....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. S226 , 2018
Link: https://doi.org/10.1016/..
 
1-15